These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22160394)

  • 1. Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.
    Cui G; Song B; Turki HW; McCarty NA
    Pflugers Arch; 2012 Mar; 463(3):405-18. PubMed ID: 22160394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents.
    Cai Z; Lansdell KA; Sheppard DN
    Br J Pharmacol; 1999 Sep; 128(1):108-18. PubMed ID: 10498841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional arrangement of the 12th transmembrane region in the CFTR chloride channel pore based on functional investigation of a cysteine-less CFTR variant.
    Qian F; El Hiani Y; Linsdell P
    Pflugers Arch; 2011 Oct; 462(4):559-71. PubMed ID: 21796338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations in the pore region directly or indirectly affect glibenclamide block of the CFTR chloride channel.
    Gupta J; Linsdell P
    Pflugers Arch; 2002 Mar; 443(5-6):739-47. PubMed ID: 11889571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing an open CFTR pore with organic anion blockers.
    Zhou Z; Hu S; Hwang TC
    J Gen Physiol; 2002 Nov; 120(5):647-62. PubMed ID: 12407077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of Au(CN)(2)(-) binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl(-) channel pore.
    Gong X; Burbridge SM; Cowley EA; Linsdell P
    J Physiol; 2002 Apr; 540(Pt 1):39-47. PubMed ID: 11927667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state interactions of glibenclamide with CFTR: evidence for multiple sites in the pore.
    Zhang ZR; Zeltwanger S; McCarty NA
    J Membr Biol; 2004 May; 199(1):15-28. PubMed ID: 15366420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations at arginine 352 alter the pore architecture of CFTR.
    Cui G; Zhang ZR; O'Brien AR; Song B; McCarty NA
    J Membr Biol; 2008 Mar; 222(2):91-106. PubMed ID: 18421494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent interactions of glibenclamide with CFTR: kinetically complex block of macroscopic currents.
    Zhang ZR; Cui G; Zeltwanger S; McCarty NA
    J Membr Biol; 2004 Oct; 201(3):139-55. PubMed ID: 15711774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a region of strong discrimination in the pore of CFTR.
    McCarty NA; Zhang ZR
    Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L852-67. PubMed ID: 11557589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between anion binding and anion permeability revealed by mutagenesis within the cystic fibrosis transmembrane conductance regulator chloride channel pore.
    Linsdell P
    J Physiol; 2001 Feb; 531(Pt 1):51-66. PubMed ID: 11179391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular cysteines of the cystic fibrosis transmembrane conductance regulator (CFTR) modulate channel gating.
    Ketchum CJ; Yue H; Alessi KA; Devidas S; Guggino WB; Maloney PC
    Cell Physiol Biochem; 2002; 12(1):1-8. PubMed ID: 11914543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolbutamide causes open channel blockade of cystic fibrosis transmembrane conductance regulator Cl- channels.
    Venglarik CJ; Schultz BD; DeRoos AD; Singh AK; Bridges RJ
    Biophys J; 1996 Jun; 70(6):2696-703. PubMed ID: 8744307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a murine cell line.
    Sheppard DN; Robinson KA
    J Physiol; 1997 Sep; 503 ( Pt 2)(Pt 2):333-46. PubMed ID: 9306276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis transmembrane conductance regulator (CFTR) confers glibenclamide sensitivity to outwardly rectifying chloride channel (ORCC) in Hi-5 insect cells.
    Julien M; Verrier B; Cerutti M; Chappe V; Gola M; Devauchelle G; Becq F
    J Membr Biol; 1999 Apr; 168(3):229-39. PubMed ID: 10191357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation.
    Bai Y; Li M; Hwang TC
    J Gen Physiol; 2010 Sep; 136(3):293-309. PubMed ID: 20805575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between permeation and gating in a putative pore domain mutant in the cystic fibrosis transmembrane conductance regulator.
    Zhang ZR; McDonough SI; McCarty NA
    Biophys J; 2000 Jul; 79(1):298-313. PubMed ID: 10866956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of the selectivity filter conferred by the sixth transmembrane region in the CFTR chloride channel pore.
    Gupta J; Lindsell P
    Mol Membr Biol; 2003; 20(1):45-52. PubMed ID: 12745925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of conductance by the number of fixed positive charges in the intracellular vestibule of the CFTR chloride channel pore.
    Zhou JJ; Li MS; Qi J; Linsdell P
    J Gen Physiol; 2010 Mar; 135(3):229-45. PubMed ID: 20142516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CFTR channels by a peptide toxin of scorpion venom.
    Fuller MD; Zhang ZR; Cui G; Kubanek J; McCarty NA
    Am J Physiol Cell Physiol; 2004 Nov; 287(5):C1328-41. PubMed ID: 15240343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.